Brighton Jones LLC’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,893
Closed -$487K 344
2025
Q3
$487K Buy
8,893
+2,011
+29% +$100K 0.01% 638
2025
Q2
$366K Buy
+6,882
New +$350K 0.01% 647
2018
Q3
Sell
-11,514
Closed -$688K 292
2018
Q2
$688K Sell
11,514
-25
-0.2% -$1.34K 0.09% 135
2018
Q1
$465K Sell
11,539
-930
-7% -$45.4K 0.06% 167
2017
Q4
$655K Sell
12,469
-987
-7% -$52.7K 0.08% 127
2017
Q3
$634K Sell
13,456
-4,386
-25% -$177K 0.08% 126
2017
Q2
$631K Buy
+17,842
New +$551K 0.09% 117
2016
Q4
Sell
-18,098
Closed -$336K 138
2016
Q3
$336K Buy
+18,098
New +$319K 0.05% 169

Other funds holding EXAS

Brighton Jones LLC's EXAS Position: Q4 2025 in Review

Brighton Jones LLC sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 8,893 shares — an estimated $487K sold.

Brighton Jones LLC first reported a position in EXAS in Q3 2016 and held it in 8 quarters. The position peaked at $688K in Q2 2018. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Brighton Jones LLC reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Brighton Jones LLC sold 8,893 Exact Sciences shares in Q4 2025, an estimated $487K.
  • Brighton Jones LLC first reported a position in Exact Sciences in Q3 2016 and held it in 8 quarters.
  • Brighton Jones LLC's Exact Sciences position peaked at $688K in Q2 2018.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Brighton Jones LLC's 13F filing for Q4 2025, filed 27 Jan 2026.